uniQure NV (QURE) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering uniQure NV.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 18 | $92 | $42 | $69.22 | $36.18 | 91.32% |
The Trend in the Analyst Price Target
QURE's average price target has moved down $2.81999999999999 over the prior 117 days.
QURE Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.37 | 7 | 10 | 2 | 0 | 0 | 19 |
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- The number of analysts covering the stock of QURE is greater than 91.03% of all US stocks.
- QURE has a higher upside potential (average analyst target price relative to current price) than 95.17% of stocks in the mid market cap category.
- uniQure NV's variance in analysts' estimates is less than 13.7% of all US stocks.
- QURE has a greater average analyst price target than 86.22% of Pharmaceutical Products stocks.
- uniQure NV's NA is higher than practically none of all US stocks.
In the Pharmaceutical Products industry, ACAD, ALLO and GBT are the three stocks most similar to uniQure NV regarding the price target and analyst recommendation information presented here.
Is QURE a Buy, Hold or Sell? See the POWR Ratings now!